BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16186976)

  • 1. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
    Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
    Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
    Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
    Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.
    Challagundla P; Jorgensen JL; Kanagal-Shamanna R; Gurevich I; Pierson DM; Ferrajoli A; Reyes SR; Medeiros LJ; Miranda RN
    Arch Pathol Lab Med; 2014 Jul; 138(7):903-9. PubMed ID: 24978916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
    Batata A; Shen B
    Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.
    Mehrpouri M; Sadat Hosseini M; Jafari L; Mosleh M; Shahabi Satlsar E
    Iran Biomed J; 2023 Jan; 27(1):15-22. PubMed ID: 36624655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
    Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
    Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders.
    Salomon-Nguyen F; Valensi F; Troussard X; Flandrin G
    Leuk Res; 1996; 20(11-12):909-13. PubMed ID: 9009248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
    Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
    Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
    Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
    El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
    Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL.
    Wang C; Amato D; Rabah R; Zheng J; Fernandes B
    Leuk Res; 2002 Dec; 26(12):1125-9. PubMed ID: 12443886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease.
    DiRaimondo F; Albitar M; Huh Y; O'Brien S; Montillo M; Tedeschi A; Kantarjian H; Lerner S; Giustolisi R; Keating M
    Cancer; 2002 Mar; 94(6):1721-30. PubMed ID: 11920534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
    Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
    Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.